Finland· FI-REL-REL13482
octaplasLG
A sonstige plasmaproteine product containing human plasma protein, registered in Finland by Octapharma AB. The same ATC class is registered in 4 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Sonstige plasmaproteine is registered in 4 of 19 countries.
Countries holding a registration under ATC B05AA02 (sonstige plasmaproteine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Sonstige plasmaproteine · ATC B05AA02
4 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Norwayprice
The record
At a glance
Fimea (Finland)- Active substance
- Human plasma protein
- Manufacturer
- Octapharma AB
- Country
- Finland (FI)
- ATC code
- B05AA02
- ATC class
- Sonstige Plasmaproteine
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sonstige plasmaproteine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandBerinert IV
- SpainOCTAPLASMALG (0) 45-70 MG/ML POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONOctapharma S.A.
- CzechiaCYMVIGOBiotest Pharma GmbH, Dreieich
- United KingdomOctaplas 11.5g/200ml infusion bagsOctapharma Ltd
- GermanyAlbumeonCsl Behring Gmbh
- BelgiumIntratect 50 g/lBiotest Pharma
- IrelandFlexbumin 200 g/l solution for infusionBaxalta Innovations GmbH
- United StatesOctaplasOctapharma USA Inc
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Albunorm, Alburex
- Belgium · Alburex, Human Albumin Csl Behring
- Bulgaria · Албурекс, Октапласlg
- Cyprus · Albumeon, Alburex
- Czechia · Alburex, Human Albumin Csl Behring
- Germany · Albumeon, Albunorm
- Denmark · Albumin Behring, Albunorm
- Estonia · Human Albumin Csl Behring, Octaplaslg
- Spain · Albúmina Humana Csl Behring, Albunorm
- France · Albumine Humaine Csl Behring, Albunorm
- United Kingdom (Northern Ireland) · Albumeon, Alburex
- Greece · Albumeon, Alburex
- Croatia · Albumeon, Albunorm
- Hungary · Alburex, Human Albumin Csl Behring
- Ireland · Alburex, Human Albumin Csl Behring
- Iceland · Albumin Behring, Albunorm
- Italy · Albumeon, Albunorm
- Lithuania · Human Albumin Csl Behring, Octaplasma
- Luxembourg · Alburex, Human Albumin Csl Behring
- Latvia · Human Albumin Csl Behring, Octaplasma
- Malta · Albumeon, Alburex
- Netherlands · Albunorm, Alburex
- Norway · Albumin Behring, Albunorm
- Poland · Alburex, Human Albumin Csl Behring
- Portugal · Albumina Humana Csl Behring, Alburex
- Romania · Albumeon, Alburex
- Sweden · Albumin Behring, Albunorm
- Slovenia · Alburex, Humani Albumin Csl Behring
- Slovakia · Alburex, Human Albumin Csl Behring
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1372b3b-5dc6-4f41-9068-11efe6500c70 GET /v1/drugs/e1372b3b-5dc6-4f41-9068-11efe6500c70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "infuusioneste, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": null,
"atc_label": "muut plasman proteiinifraktiot",
"ma_number": "15619",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL13482",
"authorised_at": "2000-10-23"
}See everything about sonstige plasmaproteine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.